These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1337493)

  • 1. [Frequent point mutations in the p53 tumor suppressor gene in human vulvar cancer].
    Speiser P; Schmid W; Czervenka K; Peschke M; Zeillinger R; Kubista E
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():31-2. PubMed ID: 1337493
    [No Abstract]   [Full Text] [Related]  

  • 2. [Precancerous and early stages of vulvar cancer].
    Pickel H
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():14. PubMed ID: 1337489
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic recommendations for intra-epithelial neoplasms of the vulva].
    Krauer F
    Arch Gynecol Obstet; 1991; 249 Suppl():S64-7. PubMed ID: 1665689
    [No Abstract]   [Full Text] [Related]  

  • 4. [Overexpression of p53 as prognosis factor in vulvar carcinoma].
    Kohlberger P; Breitenecker G; Gitsch G; Sliutz G; Kölbl H; Tschachler E; Reinthaller A; Kainz C
    Gynakol Geburtshilfliche Rundsch; 1996; 36(1):40-1. PubMed ID: 8737523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical examination oncogenic c-erb-b2, egf-r proteins and antioncogenic p53 protein in vulvar cancers HPV-16 positive and negative].
    Kedzia W; Goździcka-Józefiak A; Kedzia H; Spaczyński M
    Ginekol Pol; 2000 Feb; 71(2):63-9. PubMed ID: 10765601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva.
    van der Avoort IA; van de Nieuwenhof HP; Otte-Höller I; Nirmala E; Bulten J; Massuger LF; van der Laak JA; Slootweg PJ; de Hullu JA; van Kempen LC
    Hum Pathol; 2010 Oct; 41(10):1475-85. PubMed ID: 20656324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up].
    Riethdorf S; Friedrich RE; Sühwold J; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T
    Mund Kiefer Gesichtschir; 1998 Jan; 2(1):30-4. PubMed ID: 9522570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of p53 gene protein in squamous cell carcinoma and precancerous lesion of vulva].
    Su B; Wang K; Liu E
    Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):651-3. PubMed ID: 8745487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors and clinical characteristic patients with vulvar cancer].
    Ciszko B; Pochwałowski M; St Gabryś M
    Ginekol Pol; 2006 Dec; 77(12):914-21. PubMed ID: 17373116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Precancerous conditions and early stages of vulvar cancer].
    Baltzer J
    Arch Gynecol Obstet; 1989; 245(1-4):498-503. PubMed ID: 2552937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
    Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
    Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma.
    Del Pino M; Rodriguez-Carunchio L; Ordi J
    Histopathology; 2013 Jan; 62(1):161-75. PubMed ID: 23190170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic challenge of vulvar squamous cell carcinoma: Clinical manifestations and unusual human papillomavirus types.
    Sagdeo A; Gormley RH; Abuabara K; Tyring SK; Rady P; Elder DE; Kovarik CL
    J Am Acad Dermatol; 2014 Mar; 70(3):586-8. PubMed ID: 24528909
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of TP53 mutations in vulvar carcinomas.
    Choschzick M; Hantaredja W; Tennstedt P; Gieseking F; Wölber L; Simon R
    Int J Gynecol Pathol; 2011 Sep; 30(5):497-504. PubMed ID: 21804386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time series analysis of TP53 gene mutations in recurrent HPV-negative vulvar squamous cell carcinoma.
    Regauer S; Kashofer K; Reich O
    Mod Pathol; 2019 Mar; 32(3):415-422. PubMed ID: 30291345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous Cell Carcinoma of the Vulva: A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR).
    Dong F; Kojiro S; Borger DR; Growdon WB; Oliva E
    Am J Surg Pathol; 2015 Aug; 39(8):1045-53. PubMed ID: 26171917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of VEGF, KDR, p53, E6 HPV16 and HPV18 in vulvar and cervix cancer].
    Michalski B; Mazurek U; Olejek A; Kuśmierz D; Poreba R; Witek A; Wilczok T
    Wiad Lek; 2000; 53(5-6):240-6. PubMed ID: 10983377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of wild-type p53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer.
    Vanin K; Scurry J; Thorne H; Yuen K; Ramsay RG
    J Invest Dermatol; 2002 Nov; 119(5):1027-33. PubMed ID: 12445188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia.
    Gasco M; Sullivan A; Repellin C; Brooks L; Farrell PJ; Tidy JA; Dunne B; Gusterson B; Evans DJ; Crook T
    Oncogene; 2002 Mar; 21(12):1876-81. PubMed ID: 11896620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.